REARDON ANDREW (CLO & Secretary) sold 13.6% of their position (5K shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $1.52M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+340.00
Price / share
$52.27
Trade value
$17.77K
% of position
Common Stock
Shares
−833.00
Price / share
$302.51
Trade value
$251.99K
% of position
Common Stock
Shares
−1.98K
Price / share
$303.54
Trade value
$599.80K
% of position
Common Stock
Shares
−1.53K
Price / share
$304.52
Trade value
$467.43K
% of position
Common Stock
Shares
−404.00
Price / share
$306.18
Trade value
$123.70K
% of position
Common Stock
Shares
−235.00
Price / share
$307.19
Trade value
$72.19K
% of position
Common Stock
Shares
−17.00
Price / share
$307.74
Trade value
$5.23K
% of position
Net shares
−4.66K
Net value
-$1.50M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/2/2026 | M · Option Exercise | +340.00 | $52.27 | $17.77K | 0.9% | 36.51K | 36.85K |
| Common Stock Direct | 10/2/2026 | S · Sale | −833.00 | $302.51 | $251.99K | 2.3% | 36.85K | 36.02K |
| Common Stock Direct | 10/2/2026 | S · Sale | −1.98K | $303.54 | $599.80K | 5.5% | 36.02K | 34.05K |
| Common Stock Direct | 10/2/2026 | S · Sale | −1.53K | $304.52 | $467.43K | 4.5% | 34.05K | 32.51K |
| Common Stock Direct | 10/2/2026 | S · Sale | −404.00 | $306.18 | $123.70K | 1.2% | 32.51K | 32.11K |
| Common Stock Direct | 10/2/2026 | S · Sale | −235.00 | $307.19 | $72.19K | 0.7% | 32.11K | 31.87K |
| Common Stock Direct | 10/2/2026 | S · Sale | −17.00 | $307.74 | $5.23K | 0.1% | 31.87K | 31.85K |
| Total | −4.66K | -$1.50M | ||||||
Employee Stock Option (right to buy)
Common Stock
340.00 shares
Shares
−340.00
Strike price
52.27
Held after
29.10K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock340.00 shares | 10/2/2026 | M · Option Exercise | −340.00 | 52.27 | — | 29.10K |